IRIS
CENTONZE, DIEGO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 145.243
AS - Asia 19.544
EU - Europa 13.798
SA - Sud America 2.495
Continente sconosciuto - Info sul continente non disponibili 1.882
AF - Africa 223
OC - Oceania 55
AN - Antartide 1
Totale 183.241
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 144.669
SG - Singapore 9.054
CN - Cina 3.490
IT - Italia 2.715
BR - Brasile 2.090
HK - Hong Kong 1.930
RU - Federazione Russa 1.895
UA - Ucraina 1.819
DE - Germania 1.682
KR - Corea 1.544
IE - Irlanda 1.468
VN - Vietnam 1.276
FR - Francia 840
GB - Regno Unito 812
BD - Bangladesh 736
SE - Svezia 684
FI - Finlandia 544
JP - Giappone 469
PL - Polonia 369
NL - Olanda 326
CA - Canada 305
IN - India 248
AR - Argentina 155
ID - Indonesia 127
ES - Italia 107
MX - Messico 104
TR - Turchia 100
IQ - Iraq 98
ZA - Sudafrica 86
AT - Austria 85
BE - Belgio 64
CZ - Repubblica Ceca 64
EC - Ecuador 58
UZ - Uzbekistan 52
EU - Europa 50
CL - Cile 49
RO - Romania 49
AU - Australia 47
IR - Iran 39
PH - Filippine 38
BG - Bulgaria 36
MY - Malesia 36
CO - Colombia 35
JM - Giamaica 35
SA - Arabia Saudita 35
MA - Marocco 34
PY - Paraguay 34
LT - Lituania 32
CH - Svizzera 29
PK - Pakistan 27
AE - Emirati Arabi Uniti 26
GR - Grecia 24
KE - Kenya 23
VE - Venezuela 23
CR - Costa Rica 22
DK - Danimarca 22
KG - Kirghizistan 22
PE - Perù 21
UY - Uruguay 21
NP - Nepal 20
TN - Tunisia 20
EG - Egitto 19
PT - Portogallo 19
AL - Albania 18
IL - Israele 18
HN - Honduras 17
JO - Giordania 17
DM - Dominica 16
HR - Croazia 16
KZ - Kazakistan 16
TH - Thailandia 16
TW - Taiwan 16
DO - Repubblica Dominicana 15
DZ - Algeria 15
RS - Serbia 14
TT - Trinidad e Tobago 14
AZ - Azerbaigian 13
OM - Oman 12
LB - Libano 11
NO - Norvegia 11
GT - Guatemala 9
SI - Slovenia 9
BO - Bolivia 8
HU - Ungheria 8
A2 - ???statistics.table.value.countryCode.A2??? 7
BH - Bahrain 7
CY - Cipro 7
KH - Cambogia 7
LV - Lettonia 7
NI - Nicaragua 7
SV - El Salvador 7
BN - Brunei Darussalam 6
NG - Nigeria 6
NZ - Nuova Zelanda 6
PA - Panama 6
SK - Slovacchia (Repubblica Slovacca) 6
AM - Armenia 5
MN - Mongolia 5
MT - Malta 5
PR - Porto Rico 5
Totale 181.340
Salva come PNG Salva come JPEG
Città #
Woodbridge 39.298
Wilmington 37.935
Houston 32.864
Fairfield 4.471
Singapore 4.066
Ann Arbor 3.272
Ashburn 2.664
San Jose 1.928
Hong Kong 1.891
Seattle 1.807
Chandler 1.739
Jacksonville 1.604
Cambridge 1.529
Dublin 1.420
Beijing 1.118
Medford 1.025
Council Bluffs 843
New York 740
The Dalles 718
Santa Clara 714
Rome 602
Dearborn 561
Los Angeles 504
Lawrence 486
Ho Chi Minh City 405
Dallas 402
Tokyo 397
Buffalo 378
Zhengzhou 351
Hanoi 280
Hangzhou 277
Kraków 273
Moscow 259
Lauterbourg 245
Mülheim 241
San Diego 239
Milan 232
São Paulo 215
Menlo Park 199
Norwalk 173
Munich 159
Orem 152
London 142
Chicago 141
Redwood City 107
Helsinki 102
Shanghai 101
Guangzhou 96
San Mateo 86
Lappeenranta 85
Frankfurt am Main 84
North Bergen 83
Redondo Beach 82
Brooklyn 81
Montreal 81
Nuremberg 81
Mountain View 80
Toronto 79
Chennai 78
University Park 78
Jakarta 74
Falls Church 71
Naples 69
Atlanta 67
Rio de Janeiro 65
Seoul 65
Verona 63
Warsaw 63
San Francisco 61
Phoenix 60
Saint Petersburg 60
Detroit 59
Amsterdam 56
Brussels 56
Hefei 56
Nanjing 56
Palo Alto 55
Columbus 53
Philadelphia 52
Manchester 51
Boardman 50
Denver 50
Johannesburg 50
Salt Lake City 50
Belo Horizonte 49
Brno 46
Colorado Springs 46
Haiphong 46
Stockholm 46
Mcallen 45
Da Nang 41
Florence 40
Boston 39
Brasília 39
Tashkent 37
Vienna 37
Kunming 36
Paris 36
Mexico City 35
Bar Harbor 34
Totale 152.407
Salva come PNG Salva come JPEG
Nome #
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression 732
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis 669
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 620
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 611
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 610
TRPV1 channels facilitate glutamate transmission in the striatum 603
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 600
Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma 597
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 592
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 585
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? 579
Neurophysiology of synaptic functioning in multiple sclerosis 575
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 554
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 554
K Index in cerebrospinal fluid: a valid tool in multiple sclerosis diagnosis 532
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 531
miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation 530
KFLC Index utility in multiple sclerosis diagnosis: Further confirmation 528
The cross-cultural adaptation and psychometric validation of the MSSS-88 for use in Italian patients with multiple sclerosis 527
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 526
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients 521
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 521
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 520
Effects of postural exercises in patients with Parkinson's disease and Pisa syndrome: A pilot study 520
Connectivity Between Posterior Parietal Cortex and Ipsilateral Motor Cortex Is Altered in Schizophrenia 519
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 515
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 512
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 511
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 508
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 508
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy 507
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 506
Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes 503
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 499
TRPV1 channels regulate cortical excitability in humans 492
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 491
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 485
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 485
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 485
Subclinical central inflammation is risk for RIS and CIS conversion to MS 482
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 481
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads 481
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 480
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 479
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 479
Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes 478
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 477
Muscarinic IPSPs in rat striatal cholinergic interneurones 476
Abnormal brain lateralization and connectivity in schizophrenia 476
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis 476
Treatment decisions for patients with active multiple sclerosis 475
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 474
Synaptic transmission in the striatum: from plasticity to neurodegeneration 473
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis 472
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 472
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 472
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells 471
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 471
Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans 470
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 470
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 470
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 468
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 468
Gabaergic and glutamatergic synaptic transmissions are altered after cuprizone exposure: implication for schizophrenia and demyelinating diseases 468
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 468
A Substrate Trapping Mutant Form of Striatal-Enriched Protein Tyrosine Phosphatase Prevents Amphetamine-Induced Stereotypies and Long-Term Potentiation in the Striatum 467
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis 467
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 466
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 465
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 465
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment 465
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 464
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis 464
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 464
Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis 464
Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis 463
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 463
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 462
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 461
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis 461
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 461
Disability in multiple sclerosis: When synaptic long-term potentiation fails 461
D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801 460
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 460
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 460
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis 459
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 459
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes 458
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 457
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis 456
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 456
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 455
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 455
Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis 455
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis 455
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 453
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 452
Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management 452
Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons 451
Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis 451
Totale 49.677
Salva come PNG Salva come JPEG
Categoria #
all - tutte 440.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 440.259
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.535 0 335 187 239 107 671 203 201 427 541 219 1.405
2022/20235.738 745 376 290 610 344 1.499 546 291 395 41 446 155
2023/20241.872 259 72 135 110 161 433 156 98 34 64 33 317
2024/202513.492 356 2.704 1.245 654 477 1.041 1.003 507 1.040 1.084 1.894 1.487
2025/202620.387 1.509 1.076 2.284 1.299 2.034 617 2.476 2.484 2.393 2.015 1.163 1.037
2026/20272.173 1.110 1.063 0 0 0 0 0 0 0 0 0 0
Totale 183.241